20 Years of Research dedicated
to Gut Microbiota

Patrice D. Cani is a senior researcher, entrepreneur, and most of all, a teacher. His main research interests are the investigation of interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the immune system in the context of obesity, type 2 diabetes, cardiometabolic disorders and cancer.

Peer-Reviewed publications
Invited speaker
Scientific awards

Research Experience

Patrice D. Cani is a Registered Dietitian Nutritionist (RDN), he has a M.Sc. in Nutrition and another M.Sc. in Health Sciences,  and PhD in Biomedical Sciences (physiology,  metabolism and nutrition) from the Faculty of Medicine of the University of Louvain (UCLouvain), Brussels, Belgium. He has been visiting professor at the Imperial College London between 2010 and 2019.

Today, he is Professor of Molecular Metabolism and Nutrition, he is senior researcher from the Belgian Fund for Scientific Research (WELBIO-FRS-FNRS) and team leader in the  Metabolism and Nutrition lab  at the  Louvain Drug Research Institute  (LDRI) from the UCLouvain. In 2007, he published the discovery of the concept of metabolic endotoxemia, and more recently, he discovered the beneficial role of the bacteria Akkermansia muciniphila on obesity and cardiometabolic risk factors (published in PNAS 2013, in Nature Medicine 2017 and in Nature Medicine 2019).

He is the author and co-author of more than 325 scientific research publications, reviews and book chapters. Co-inventor of 10 patents and co-founder of “A-Mansia Biotech”, The Akkermansia Company.

bugs as drugs book patrice cani robert a. britton

A Book to recommend?

In Bugs as Drugs, edited by Robert A. Britton and Patrice D. Cani. They have assembled a fascinating collection of reviews that chart the history, current efforts, and future prospects of using microorganisms to fight disease and improve health. Sections cover traditional uses of probiotics, next-generation microbial therapeutics, controlling infectious diseases, and indirect strategies for manipulating the host microbiome.

Out in 2018 - Check it out here